Adverum Biotechnologies, Inc. (ADVM) - Stock Prices, Stock Peers & Analysis

Home
ADVM

Company Name	Adverum Biotechnologies, Inc.
Symbol	ADVM
Currency	USD
Price	6.99
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	145,398,291
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	6.38 - 29.7
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Laurent Fischer
Website	https://www.adverum.com

An error occurred while fetching data.

About Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema.